67496-78-0

Basic information

• Product Name: quinuclidin-4-ylMethanaMine
• Synonyms: quinuclidin-4-ylMethanaMine;1-Azabicyclo[2.2.2]octane-4-methanamine;4-Aminomethylquinuclidine;1-AZABICYCLO[2.2.2]OCTAN-4-YLMETHANAMINE;C-(1-Aza-bicyclo[2.2.2]oct-4-yl)-MethylaMine;1-Azabicyclo[2.2.2]octane-4-methanamine 4-Aminomethylquinuclidine;Quinnclidine-4-ylmethylamine;(1-Aza-bicyclo[2.2.2]oct-4-yl)-methylamine
• CAS NO: 67496-78-0
• Molecular Formula: C₈H₁₆N₂
• Molecular Weight: 140.22604
• EINECS: 200-258-5
• Mol File: 67496-78-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 186℃
• Flash Point: 63℃
• Appearance: /
• Density: 1.04
• Storage Temp.: 2-8°C(protect from light)
• PKA: 10.67±0.10(Predicted)
• CAS DataBase Reference: quinuclidin-4-ylMethanaMine(CAS DataBase Reference)
• NIST Chemistry Reference: quinuclidin-4-ylMethanaMine(67496-78-0)
• EPA Substance Registry System: quinuclidin-4-ylMethanaMine(67496-78-0)

Safety Data

• Hazardous Substances Data: 67496-78-0(Hazardous Substances Data)

Usage

General Description

Quinuclidin-4-yl methanamine, also known as Quinuclidine-4-methylamine, is a type of organic compound derived from quinuclidine. This chemical is often used in the development of pharmaceuticals and other drug compounds due to its capacity to act as a ligand, a molecule that binds to a central atom to form a coordination complex. Its chemical formula is C8H16N2 and it falls under the category of nitrogen heterocyclic compounds. Despite the potential toxic health risks it might present, its applications in medicinal chemistry make it vital in the pharmaceutical field.

InChI:InChI=1S/C8H16N2/c9-7-8-1-4-10(5-2-8)6-3-8/h1-7,9H2

Upstream product

• 26458-78-6 4-cyanoquinuclidine 

Downstream Products

• 165379-18-0 N-(1-azabicyclo[2.2.2]octan-4-ylmethyl)-2'-oxo-spiro[cyclopropane-1,3'-[3'H]indole]-1'(2'H)-carboxamide 
• 167753-24-4 3-(quinuclidin-4-yl)methyl-4-phenyl-3,4-dihydro-2(1H)-quinazolinone 
• 1135935-59-9 N-(quinuclidin-4-ylmethyl)-1H-indole-3-carboxamide 
• 1186331-94-1 3-(7-{6-[(1-azabicyclo[2.2.2]oct-4-ylmethyl)amino]pyridin-3-yl}-2-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)phenol 
• 1186334-45-1 N-(1-aza-bicyclo[2.2.2]oct-4-ylmethyl)-[3-(3-methoxy-phenyl)-2-pyridin-4-yl-pyrazolo[1,5,a]pyrimidin-7-yl]-amine 
• 1236120-93-6 C₁₈H₂₀ClN₃OS 
• 1236121-57-5 C₂₁H₂₃ClN₂O 
• 1262420-78-9 lithium 3-((quinuclidin-4-ylmethylamino)methyl)-1H-indazole-4-carboxylate 
• 1262419-61-3 4-(quinuclidin-4-ylmethyl)-3,4-dihydropyrazolo[3,4,5-de]isoquinolin-5(1H)-one 
• 1262420-77-8 methyl 3-((quinuclidin-4-ylmethylamino)methyl)-1H-indazole-4-carboxylate 
• 1262420-81-4 methyl 1-(2-(quinuclidin-4-ylmethylamino)ethyl)-1H-indazole-7-carboxylate 
• 1225209-21-1 2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(quinuclidin-4-ylmethyl)benzamide 
• 1338730-21-4 C₃₅H₃₇N₃O₅ 
• 1338729-18-2 C₂₂H₂₇N₃O₄ 

Relevant articles and documents

PROGRANULIN MODULATORS AND METHODS OF USING THE SAME

Provided herein are compounds that modulate progranulin and methods of using the compounds in progranulin-associated disorders, such as Frontotemporal dementia (FTD).

2′ Biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR

Biaryl amides were discovered as novel and subtype selective M1 muscarinic acetylcholine receptor agonists. The identification, synthesis, and initial structure-activity relationships that led to compounds 3j and 4c, possessing good M1 agonist potency and intrinsic activity, and subtype selectivity for M1 over M2-5, are described.

THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS

The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease